摘要
衰老是指所有细胞,组织,器官和整个生物体中的自然过程和普遍现象。长非编码RNA(lncRNA)是长度为200个核苷酸的非编码RNA。LncRNA生长停滞特异性5(lncRNA GAS5)在癌症中经常被下调。已经发现lncRNA GAS5的积累能够抑制癌症的生长,侵袭和转移,同时增强细胞对化疗药物的敏感性。LncRNA GAS5可以是一种信号蛋白,在不同的触发条件下特异性转录。随后,它作为信号节点参与许多路径中的信号传输。LncRNA GAS5与多种miRNA密切相关,建议在三种作用模式(即信号,诱饵和引导)下参与信号通路。LncRNA GAS5被发现参与不同的年龄相关疾病(例如,类风湿性关节炎,2型糖尿病,动脉粥样硬化,骨关节炎,骨质疏松症,多发性硬化症,癌症等)。本研究主要总结了lncRNA GAS5对年龄相关疾病所发挥的调控作用。
关键词: lncRNA ,GAS5,与年龄有关的疾病,动脉粥样硬化,2型糖尿病,癌症。
Current Medicinal Chemistry
Title:Long Non-Coding RNA GAS5 in Age-Related Diseases
Volume: 29 Issue: 16
关键词: lncRNA ,GAS5,与年龄有关的疾病,动脉粥样硬化,2型糖尿病,癌症。
摘要: Aging refers to a natural process and a universal phenomenon in all cells, tissues, organs, and the whole organism. Long non-coding RNAs (lncRNAs) are non-coding RNAs with a length of 200 nucleotides. LncRNA growth arrest-specific 5 (lncRNA GAS5) is often down-regulated in cancer. The accumulation of lncRNA GAS5 has been found to be able to inhibit cancer growth, invasion, and metastasis while enhancing the sensitivity of cells to chemotherapy drugs. LncRNA GAS5 can be a signaling protein, which is specifically transcribed under different triggering conditions. Subsequently, it is involved in signal transmission in numerous pathways as a signal node. LncRNA GAS5, with a close relationship to multiple miRNAs, was suggested to be involved in the signaling pathway under three action modes (i.e., signal, bait, and guidance). LncRNA GAS5 was found to be involved in different age-related diseases (e.g., rheumatoid arthritis, type 2 diabetes, atherosclerosis, osteoarthritis, osteoporosis, multiple sclerosis, cancer, etc.). This study mainly summarized the regulatory effect exerted by lncRNA GAS5 on age-related diseases.
Export Options
About this article
Cite this article as:
Long Non-Coding RNA GAS5 in Age-Related Diseases, Current Medicinal Chemistry 2022; 29 (16) . https://dx.doi.org/10.2174/0929867328666211027123932
DOI https://dx.doi.org/10.2174/0929867328666211027123932 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
p73 as a Pharmaceutical Target for Cancer Therapy
Current Pharmaceutical Design Novel Vaginal Drug Delivery Systems: A Review
Current Drug Therapy Evaluation of the Risk/Benefit Ratio of Old and New Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Current Pharmaceutical Design Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
Current Medicinal Chemistry Novel Insights Into the Role of MicroRNA in Lung Cancer Resistance to Treatment and Targeted Therapy
Current Cancer Drug Targets CC Chemokine Receptor Small Molecule Antagonists in the Treatment of Rheumatoid Arthritis and Other Diseases: A Current View
Current Topics in Medicinal Chemistry Chemistry and Pharmacology of Natural Catechins from <i>Camellia sinensis</i> as Anti-MRSA Agents
Current Topics in Medicinal Chemistry Agonists and Antagonists of Protease Activated Receptors (PARs)
Current Medicinal Chemistry Carnosine and Diabetic Nephropathy
Current Medicinal Chemistry 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Regulation by Antioxidant Compounds: New Therapeutic Tools for Hypercholesterolemia?
Current Molecular Medicine The Role of Essential Oils and the Biological Detoxification in the Prevention of Aflatoxin Borne Diseases
Current Topics in Medicinal Chemistry Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties
Current Pharmaceutical Design HIV-1 Matrix Protein p17 and its Receptors
Current Drug Targets Targeting Neuropathic Pain: Pathobiology, Current Treatment and Peptidomimetics as a New Therapeutic Opportunity
Current Medicinal Chemistry Perioperative Management of Patients on Adenosine Diphosphate Inhibitors in the Era of Drug-Eluting Stents: Review of the Literature and Clinical Implications
Current Medicinal Chemistry 23Na Magnetic Resonance Imaging for the Determination of Myocardial Viability: The Status and the Challenges
Current Vascular Pharmacology Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells
Mini-Reviews in Medicinal Chemistry Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets
Current Topics in Medicinal Chemistry Cholesteryl Ester Transfer Protein: Pharmacological Inhibition for the Modulation of Plasma Cholesterol Levels and Promising Target for the Prevention of Atherosclerosis.
Current Topics in Medicinal Chemistry